agent.disease-and-advisory

摘要

Enhanced surveillance data on laboratory confirmed pertussis (whooping cough) cases reported in England during 2025, tracking disease burden and trends.

詳細內容

This research publication presents laboratory confirmed cases of pertussis reported to the enhanced pertussis surveillance programme in England for 2025. Pertussis (whooping cough) is a highly contagious respiratory disease caused by Bordetella pertussis.

Enhanced surveillance includes:

• Laboratory confirmed case counts
• Age distribution of cases
• Geographic distribution across England
• Temporal trends and seasonal patterns
• Vaccination status of cases
• Severity and outcomes (hospitalizations, deaths)

Clinical significance: Pertussis is particularly dangerous for:

• Infants: Highest risk of severe disease and death
• Unvaccinated children: Increased susceptibility
• Adolescents and adults: Often milder but can transmit to vulnerable infants

Key surveillance findings typically include:

• Cyclical patterns (3-5 year peaks)
• Impact of maternal vaccination program
• Vaccine effectiveness estimates
• Outbreak detection and response

Public health importance: The surveillance data informs:

• Vaccination program effectiveness evaluation
• Need for booster doses
• Maternal vaccination program impact
• Early outbreak detection
• Public health messaging and interventions

Despite high vaccination coverage, pertussis remains a public health challenge due to waning immunity and continued circulation. Enhanced surveillance is essential for monitoring trends and guiding control strategies.

相關疾病

Pertussis (whooping cough), Bordetella pertussis

---

萃取時間: 2026-02-05T22:58:00Z 資料來源: UK Health Security Agency